Cellect Biotechnology's ApoGraft technology demonstrated positive results for orthopedic applications in a study.
Biologics
Kuros Biosciences submitted an FDA 510(k) clearance regulatory package for its Fibrin-PTH (KUR-113).
Reinvent Biologics is a regenerative medicine company.
Platelet-rich plasma injections and stem cell therapies are ushering in a "new dawn" in orthopedics, according to Jason Arora, DO, a board-certified interventional spine and pain management physician at West Orange, N.J.-based Atlantic Spine Center.
Cynata Therapeutics entered into a licensing agreement with Fujifilm Holdings to begin stem cell therapy clinical trials in the U.S. and Japan, according to Nikkei Asian Review.
Advertisement
New York City-based Hospital for Special Surgery researchers launched a clinical trial to assess the effects of Organogenesis' ReNu on knee function.
A stem cell provider registry program will improve the quality of treatments, wrote Fabio Rossi, MD, PhD, and Judy Illes, PhD, in an op-ed in the Vancouver Sun.
Baxter International received FDA 510(k) clearance for its Altapore Bioactive Bone Graft for spinal fusion.
Minneapolis-based University of Minnesota Medical School researchers are using 3D technology to identify skeletal muscle stem cells for transplantation, according to Health Data Management.
Female ankylosing spondylitis patients do not respond as well to biologic treatment as their male counterparts, according to a study presented at the International Congress on Spondyloarthritides 2018 in Gent, Belgium, Oct. 4-8, and reported in Medscape.